Slide background

aI7A444
Slide background
Slide background

Contact Us

NYGC Diagnostic Tests

NYGC’s clinical sequencing laboratory offers tests that are intended to further the mission of NYGC – translating genomic research into clinical solutions for serious disease. The laboratory received New York State Clinical Laboratory Evaluation Program (CLEP) certification from the NY State (NYS) Department of Health (DOH) in May 2014.  Its first two genomics laboratory developed tests (LDT), a constitutional whole-exome sequencing (WES) test for undiagnosed disease and a targeted variant test (Sanger-sequencing based assay to confirm the mutations identified by research NGS for constitutional diseases), received CLEP approval from the NYS DOH in March 2015.  The clinical lab participates in the College of American Pathologists (CAP) proficiency testing for our CLEP approved clinical tests.

In addition to its own approved tests, NYGC’s clinical laboratory can generate sequencing data for institutions that would like to offer next-generation sequencing laboratory-developed tests but do not have the infrastructure to generate the data. It can also be used to support research efforts that require CLIA-standard grade sequencing data.

Vaidehi Jobanputra, PhD, FACMG
Director, Molecular Diagnostics
For inquiries, please contact us at
clinical@nygenome.org